Loss of TIMP-3 promotes tumor invasion via elevated IL-6 production and predicts poor survival and relapse in HPV-infected non-small cell lung cancer

American Journal of Pathology

Volumn 181, Issue 5, 2012, Pages 1796-1806

  Wu, De Wei ^a   Tsai, Lung Hung ^b   Chen, Po Ming ^b   Lee, Ming Ching ^c   Wang, Lee ^b   Chen, Chih Yi ^d   Cheng, Ya Wen ^a   Lee, Huei ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; DNA METHYLTRANSFERASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PLASMID DNA; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR ALPHA;

AGED; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CELL INVASION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENETIC TRANSFECTION; HETEROZYGOSITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; PROTEIN METHYLATION; RECURRENCE FREE SURVIVAL;

ADENOCARCINOMA; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DNA METHYLATION; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; INTERLEUKIN-6; KAPLAN-MEIER ESTIMATE; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS; RECURRENCE; SMOKING; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 84868092762     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.07.032     Document Type: Article

References (58)

1. S. Sun, J.H. Schiller, A.F. Gazdar Lung cancer in never smokers - a different disease Nat Rev Cancer 7 2007 778 790 (Pubitemid 47463669)
2. H. Shigematsu, L. Lin, T. Takahashi, M. Nomura, M. Suzuki, I.I. Wistuba, K.M. Fong, H. Lee, S. Toyooka, N. Shimizu, T. Fujisawa, Z. Feng, J.A. Roth, J. Herz, J.D. Minna, A.F. Gazdar Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers J Natl Cancer Inst 97 2005 339 346 (Pubitemid 40425952)
3. L.W. Huang, S.L. Chao, P.H. Chen, H.P. Chou Multiple HPV genotypes in cervical carcinomas: improved DNA detection and typing in archival tissues J Clin Virol 29 2004 271 276
4. Y. Wu, Q. Zhang, B. Liu, G. Yu The analysis of the entire HLA, partial non-HLA and HPV for Chinese women with cervical cancer J Med Virol 80 2008 1808 1813
5. Y.W. Cheng, H.L. Chiou, G.T. Sheu, L.L. Hsieh, J.T. Chen, C.Y. Chen, J.M. Su, H. Lee The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women Cancer Res 61 2001 2799 2803 (Pubitemid 32691913)
6. N. Yeganeh, D. Curtis, A.A. Kuo Factors influencing HPV vaccination status and parental attitudes towards vaccine mandates Vaccine 28 2010 4186 4191
7. F. Aguayo, M. Anwar, C. Koriyama, A. Castillo, Q. Sun, J. Morewaya, Y. Eizuru, S. Akiba Human papillomavirus-16 presence and physical status in lung carcinomas from Asia Infect Agent Cancer 5 2010 20 26
8. Y.W. Cheng, M.F. Wu, J. Wang, K.T. Yeh, Y.G. Goan, H.L. Chiou, C.Y. Chen, H. Lee Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation Cancer Res 67 2007 10686 10693 (Pubitemid 350145894)
9. WAF1/CIP1 via Alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer Clin Cancer Res 17 2011 1895 1905
10. D.W. Wu, Y.W. Cheng, J. Wang, C.Y. Chen, H. Lee Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting Cancer Res 70 2010 10392 10401
11. Y.W. Cheng, T.C. Wu, C.Y. Chen, M.C. Chou, J.L. Ko, H. Lee Human telomerase reverse transcriptase activated by E6 oncoprotein is required for human papillomavirus-16/18-infected lung tumorigenesis Clin Cancer Res 14 2008 7173 7179
12. Y.W. Cheng, H. Lee, M.Y. Shiau, T.C. Wu, T.T. Huang, Y.H. Chang Human papillomavirus type 16/18 up-regulates the expression of interleukin-6 and antiapoptotic Mcl-1 in non-small cell lung cancer Clin Cancer Res 14 2008 4705 4712
13. J.E. Fata, K.J. Leco, E.B. Voura, H.Y. Yu, P. Waterhouse, G. Murphy, R.A. Moorehead, R. Khokha Accelerated apoptosis in the TIMP-3-deficient mammary gland J Clin Invest 108 2001 831 841 (Pubitemid 32880292)
14. A.H. Baker, S.J. George, A.B. Zaltsman, G. Murphy, A.C. Newby Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3 Br J Cancer 79 1999 1347 1355 (Pubitemid 29116789)
15. C. Chetty, S.S. Lakka, P. Bhoopathi, S. Kunigal, R. Geiss, J.S. Rao Tissue inhibitor of metalloproteinase 3 suppresses tumor angiogenesis in matrix metalloproteinase 2-down-regulated lung cancer Cancer Res 68 2008 4736 4745
16. D. Barski, M. Wolter, G. Reifenberger, M.J. Riemenschneider Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas Brain Pathol 20 2010 623 631
17. M. Nakamura, E. Ishida, K. Shimada, M. Kishi, H. Nakase, T. Sakaki, N. Konishi Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas Lab Invest 85 2005 165 175 (Pubitemid 40208920)
18. A. Wild, P. Langer, I. Celik, B. Chaloupka, D.K. Bartsch Chromosome 22q in pancreatic endocrine tumors: identification of a homozygous deletion and potential prognostic associations of allelic deletions Eur J Endocrinol 147 2002 507 513 (Pubitemid 35238147)
19. P. Gu, X. Xing, M. Tanzer, C. Rocken, W. Weichert, A. Ivanauskas, M. Pross, U. Peitz, P. Malfertheiner, R.M. Schmid, M.P. Ebert Frequent loss of TIMP-3 expression in progression of esophageal and gastric adenocarcinomas Neoplasia 10 2008 563 572 (Pubitemid 351770300)
20. K.E. Bachman, J.G. Herman, P.G. Corn, A. Merlo, J.F. Costello, W.K. Cavenee, S.B. Baylin, J.R. Graff Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers Cancer Res 59 1999 798 802 (Pubitemid 29086729)
21. S. Zochbauer-Muller, K.M. Fong, A.K. Virmani, J. Geradts, A.F. Gazdar, J.D. Minna Aberrant promoter methylation of multiple genes in non-small cell lung cancers Cancer Res 61 2001 249 255 (Pubitemid 32095725)
22. H. De Schutter, H. Geeraerts, E. Verbeken, S. Nuyts Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only Oncol Rep 21 2009 507 513
23. D.H. Jeong, M.Y. Youm, Y.N. Kim, K.B. Lee, M.S. Sung, H.K. Yoon, K.T. Kim Promoter methylation of p16. DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics Int J Gynecol Cancer 16 2006 1234 1240 (Pubitemid 43886751)
24. M.C. Liu, D.Y. Choong, C.S. Hooi, L.H. Williams, I.G. Campbell Genetic and epigenetic analysis of the TIMP-3 gene in ovarian cancer Cancer Lett 247 2007 91 97 (Pubitemid 44959410)
25. S.J. Darnton, L.J. Hardie, R.S. Muc, C.P. Wild, A.G. Casson Tissue inhibitor of metalloproteinase-3 (TIMP-3) gene is methylated in the development of esophageal adenocarcinoma: loss of expression correlates with poor prognosis Int J Cancer 115 2005 351 358 (Pubitemid 40663737)
26. N. Mino, K. Takenaka, M. Sonobe, R. Miyahara, K. Yanagihara, Y. Otake, H. Wada, F. Tanaka Expression of tissue inhibitor of metalloproteinase-3 (TIMP-3) and its prognostic significance in resected non-small cell lung cancer J Surg Oncol 95 2007 250 257
27. J. Gu, D. Berman, C. Lu, I.I. Wistuba, J.A. Roth, M. Frazier, M.R. Spitz, X. Wu Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancer Clin Cancer Res 12 2006 7329 7338 (Pubitemid 46095405)
28. F.F. Mohammed, D.S. Smookler, S.E. Taylor, B. Fingleton, Z. Kassiri, O.H. Sanchez, J.L. English, L.M. Matrisian, B. Au, W.C. Yeh, R. Khokha Abnormal TNF activity in TIMP3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration Nat Genet 36 2004 969 977 (Pubitemid 39167493)
29. R. Berry, T.J. Stevens, N.A. Walter, A.S. Wilcox, T. Rubano, J.A. Hopkins, J. Weber, R. Goold, M.B. Soares, J.M. Sikela Gene-based sequence-tagged-sites (STSs) as the basis for a human gene map Nat Genet 10 1995 415 423
30. M.S. Boguski, G.D. Schuler Establishing a human transcript map Nat Genet 10 1995 369 371
31. P. Deloukas, G.D. Schuler, G. Gyapay, E.M. Beasley, C. Soderlund, P. Rodriguez-Tomé et al. A physical map of 30,000 human genes Science 282 1998 744 746 (Pubitemid 28489386)
32. G. Gyapay, K. Schmitt, C. Fizames, H. Jones, N. Vega-Czarny, D. Spillett, D. Muselet, J.F. Prud'homme, C. Dib, C. Auffray, J. Morissette, J. Weissenbach, P.N. Goodfellow A radiation hybrid map of the human genome Hum Mol Genet 5 1996 339 346 (Pubitemid 26069576)
33. T.J. Hudson, L.D. Stein, S.S. Gerety, J. Ma, A.B. Castle, J. Silva, D.K. Slonim, R. Baptista, L. Kruglyak, S.H. Xu, X. Hu, A.M. Colbert, C. Rosenberg, M.P. Reeve-Daly, S. Rozen, L. Hui, X. Wu, C. Vestergaard, K.M. Wilson, J.S. Bae, S. Maitra, S. Ganiatsas, C.A. Evans, M.M. DeAngelis, K.A. Ingalls, R.W. Nahf, L.T. Horton Jr., M.O. Anderson, A.J. Collymore, W. Ye, V. Kouyoumjian, I.S. Zemsteva, J. Tam, R. Devine, D.F. Courtney, M.T. Renaud, H. Nguyen, T.J. O'Connor, C. Fizames, S. Fauré, G. Gyapay, C. Dib, J. Morissette, J.B. Orlin, B.W. Birren, N. Goodman, J. Weissenbach, T.L. Hawkins, S. Foote, D.C. Page, E.S. Lander An STS-based map of the human genome Science 270 1995 1945 1954
34. G.D. Schuler, M.S. Boguski, E.A. Stewart, L.D. Stein, G. Gyapay, K. Rice et al. A gene map of the human genome Science 274 1996 540 546 (Pubitemid 26360428)
35. E.A. Stewart, K.B. McKusick, A. Aggarwal, E. Bajorek, S. Brady, A. Chu, N. Fang, D. Hadley, M. Harris, S. Hussain, R. Lee, A. Maratukulam, K. O'Connor, S. Perkins, M. Piercy, F. Qin, T. Reif, C. Sanders, X. She, W.L. Sun, P. Tabar, S. Voyticky, S. Cowles, J.B. Fan, C. Mader, J. Quackenbush, R.M. Myers, D.R. Cox An STS-based radiation hybrid map of the human genome Genome Res 7 1997 422 433 (Pubitemid 27232006)
36. A.S. Wilcox, A.S. Khan, J.A. Hopkins, J.M. Sikela Use of 3′ untranslated sequences of human cDNAs for rapid chromosome assignment and conversion to STSs: implications for an expression map of the genome Nucl Acids Res 25 1991 1837 1843 (Pubitemid 21913288)
37. R. Hino, H. Uozaki, N. Murakami, T. Ushiku, A. Shinozaki, S. Ishikawa, T. Morikawa, T. Nakaya, T. Sakatani Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma Cancer Res 69 2009 2766 2774
38. L.S. Kristensen, T. Mikeska, M. Krypuy, A. Dobrovic Sensitive melting analysis after real time-methylation specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection Nucleic Acids Res 36 2008 e42
39. M.B. Treppendahl, X. Qiu, A. Sogaard, X. Yang, C. Nandrup-Bus, C. Hother, M.K. Andersen, L. Kjeldsen, L. Möllgaard, E. Hellström-Lindberg, J. Jendholm, B.T. Porse, P.A. Jones, G. Liang, K. Gronbæk Allelic methylation levels of the noncodingVTRNA2-1located on chromosome 5q31.1 predict outcome in AML Blood 119 2012 206 216
40. I. Viard-Leveugle, S. Veyrenc, L.E. French, C. Brambilla, E. Brambilla Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma J Pathol 201 2003 268 277 (Pubitemid 37258938)
41. W.W. Sung, Y.C. Wang, Y.W. Cheng, M.C. Lee, K.T. Yeh, L. Wang, J. Wang, C.Y. Chen, H. Lee A polymorphic-844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer Clin Cancer Res 17 2011 5991 5999
42. R.K. Lin, C.Y. Wu, J.W. Chang, L.J. Juan, H.S. Hsu, C.Y. Chen, Y.Y. Lu, Y.A. Tang, Y.C. Yang, P.C. Yang, Y.C. Wang Dysregulation of p53/Sp1 control leads to DNA methyltransferase-1 overexpression in lung cancer Cancer Res 70 2010 5807 5817
43. M. Karin, T. Lawrence, V. Nizet Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer Cell 124 2006 823 835 (Pubitemid 43261455)
44. W.W. Lin, M. Karin A cytokine-mediated link between innate immunity, inflammation, and cancer J Clin Invest 117 2007 1175 1183 (Pubitemid 46718402)
45. S.P. Hussain, C.C. Harris Inflammation and cancer: an ancient link with novel potentials Int J Cancer 121 2007 2373 2380 (Pubitemid 350022405)
46. H. zur Hausen Papillomaviruses and cancer: from basic studies to clinical application Nat Rev Cancer 2 2002 342 350 (Pubitemid 37328947)
47. G. D'Souza, A.R. Kreimer, R. Viscidi, M. Pawlita, C. Fakhry, W.M. Koch, W.H. Westra, M.L. Gillison Case-control study of human papillomavirus and oropharyngeal cancer N Engl J Med 356 2007 1944 1956 (Pubitemid 46740304)
48. Y. Ben-Neriah, M. Karin Inflammation meets cancer, with NF-kappaB as the matchmaker Nat Immunol 12 2011 715 723
49. J. An, D. Mo, H. Liu, M.S. Veena, E.S. Srivatsan, R. Massoumi, M.B. Rettig Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activation Cancer Cell 14 2008 394 407
50. R.A. Black TIMP3 checks inflammation Nat Genet 36 2004 934 935 (Pubitemid 39167484)
51. J.L. Luo, S. Maeda, L.C. Hsu, H. Yagita, M. Karin Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression Cancer Cell 6 2004 297 305 (Pubitemid 39222042)
52. D. Iliopoulos, H.A. Hirsch, K. Struhl An epigenetic switch involving NF-kappaB Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation Cell 139 2009 693 706
53. N. Babbar, R.A. Casero Jr. Tumor necrosis factor-alpha increases reactive oxygen species by inducing spermine oxidase in human lung epithelial cells: a potential mechanism for inflammation-induced carcinogenesis Cancer Res 66 2006 11125 11130 (Pubitemid 46009938)
54. H.H. Yeh, W.W. Lai, H.H. Chen, H.S. Liu, W.C. Su Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion Oncogene 25 2006 4300 4309 (Pubitemid 44100500)
55. J.J. Chen, Y.C. Lin, P.L. Yao, A. Yuan, H.Y. Chen, C.T. Shun, M.F. Tsai, C.H. Chen, P.C. Yang Tumor-associated macrophages: the double-edged sword in cancer progression J Clin Oncol 23 2005 953 964 (Pubitemid 46202315)
56. S. Maeda, Y. Hikiba, K. Sakamoto, H. Nakagawa, Y. Hirata, Y. Hayakawa, A. Yanai, K. Ogura, M. Karin, M. Omata Ikappa B kinasebeta/nuclear factor-kappaB activation controls the development of liver metastasis by way of interleukin-6 expression Hepatology 50 2009 1851 1860
57. E. Meylan, A.L. Dooley, D.M. Feldser, L. Shen, E. Turk, C. Ouyang, T. Jacks Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma Nature 462 2009 104 107
58. A. Nair, M. Venkatraman, T.T. Maliekal, B. Nair, D. Karunagaran NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix Oncogene 22 2003 50 58 (Pubitemid 36152883)